Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors
Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors
About this item
Full title
Author / Creator
Publisher
Dordrecht: Springer Netherlands
Journal title
Language
English
Formats
Publication information
Publisher
Dordrecht: Springer Netherlands
Subjects
More information
Scope and Contents
Contents
Cyclin-dependent kinase (CDK) 4/6 inhibitors have emerged in the treatment of metastatic hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer. However, most patients will eventually present disease progression, highlighting the inevitable resistance of cancer cells to CDK4/6 inhibition. Several s...
Alternative Titles
Full title
Mechanisms of resistance to cyclin-dependent kinase 4/6 inhibitors
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2476129008
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2476129008
Other Identifiers
ISSN
0301-4851
E-ISSN
1573-4978
DOI
10.1007/s11033-020-06100-3
